Potential target for treating triple-negative breast cancer identified

29 octubre 2014

A protein that could prevent metastasis and recurrence of breast cancer has been identified by researchers. So-called «triple-negative» breast cancer represents between 12 and 17 percent of all breast cancers. It derives its name from the lack of receptors for estrogen, progesterone and Her2. The absence of these receptors rules out proven hormone therapies such as tamoxifen. Triple-negative breast cancer can be more aggressive and is more likely to recur than other breast cancers.